Skip Navigation
Markets
Pre-Markets
U.S. Markets
Currencies
Prediction Markets
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs
Business
Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Investigations
Industrials
Retail
Wealth
Sports
Life
Small Business
Investing
Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk
Tech
Cybersecurity
AI
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide
Politics
White House
Policy
Defense
Congress
Expanding Opportunity
Video
Latest Video
Full Episodes
Livestream
Live Audio
Live TV Schedule
CNBC Podcasts
CEO Interviews
CNBC Documentaries
Digital Originals
Watchlist
Investing Club
Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
PRO
Pro News
Josh Brown
Mike Santoli
Calls of the Day
My Portfolio
Livestream
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Livestream
Menu
Make It
select
USA
INTL
Livestream
Search quotes, news & videos
Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
PRO
Livestream
Menu
Business News
Biotech and Pharma
Health
Hospitals
Biotech and Pharma
Health Insurance
Modern Medicine
Here are 4 forces that drove a tough week for stocks
Alexa LoMonaco
Sat, Jul 25th 2026
CDC says massive cyclospora outbreak is now in nine states
Annika Kim Constantino
Fri, Jul 24th 2026
Eli Lilly says it will file for approval of next-generation obesity drug in 2027
Annika Kim Constantino
Thu, Jul 23rd 2026
What Trump's generic drug tariffs could mean for patients, drugmakers and prices
Elsa Ohlen
Wed, Jul 22nd 2026
Wall Street can wait: Why one U.S. biotech firm is listing in Hong Kong first
Elaine Yu
Wed, Jul 22nd 2026
Health and Science
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Tue, Jul 21st 2026
Health and Science
What to know about testosterone replacement as U.S. military plans to test troops
Mon, Jul 20th 2026
The Bottom Line
Market case for psychedelic drugs to treat mental health gets a big buy signal
Tue, Jul 21st 2026
Health and Science
Fat cat? Weight-loss drugs may be coming for your overweight pet
Sat, Jul 18th 2026
Health and Science
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion
Thu, Jul 16th 2026
Health and Science
UnitedHealth beats quarterly estimates, hikes profit outlook
Thu, Jul 16th 2026
Trending Now
1
Ukraine strikes Iranian vessels in Caspian Sea, Tehran accuses Kyiv of 'hostile and criminal act'
2
Trump sued hours after new tariffs take effect, as experts say they may not hold up
3
Some high-earning investors will soon owe taxes on years of deferred capital gains
4
U.S. appeals court rules Trump cannot implement mail-in voting order
5
New UK Prime Minister Burnham says he would be prepared to call out Trump
More In Biotech and Pharma
Analysis
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways
Wed, Jul 15th 2026
Analysis
Johnson & Johnson has a chance to show it's more than just a rotation winner
Tue, Jul 14th 2026
Biotech's recovery isn't a 'head fake.'Â These 3 stocks could lead the next leg up
Tue, Jul 14th 2026
Health and Science
A tiny GLP-1 implant is the latest bet to help patients maintain weight loss
Sat, Jul 11th 2026
Health and Science
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?
Sat, Jul 11th 2026
Health and Science
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer
Fri, Jul 10th 2026
Analysis
Impressive growth of Eli Lilly's obesity business is coming from all over the world
Fri, Jul 10th 2026
Pharmaceuticals
AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse
Tue, Jul 21st 2026
Healthy Returns
Employers aren't expanding coverage of GLP-1 obesity drugs, survey says
Wed, Jul 8th 2026
Mad Money
Jim Cramer says this former Covid market darling is finally investable again
Thu, Jul 2nd 2026
Healthy Returns
Walmart, CVS step in to help seniors with Medicare coverage of obesity drugsÂ
Wed, Jul 1st 2026
Politics
FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes
Tue, Jun 30th 2026
Health and Science
Medicare will start covering obesity drugs. Here's what patients should know
Tue, Jun 30th 2026
Markets
French biotech stock soars 40% after new data on experimental medicine
Tue, Jun 30th 2026
Health and Science
FDA names first companies chosen for faster review of new manufacturing plants
Tue, Jul 21st 2026
Health and Science
Medicare is about to cover obesity drugs — but many seniors may not know it yet
Sun, Jun 28th 2026
Health and Science
Estrogen patches are hard to find, and it may not be resolved any time soon
Fri, Jun 26th 2026
CNBC Cures
Chan Zuckerberg Initiative's Biohub to open new rare disease funding round
Thu, Jun 25th 2026
This life sciences stock has a secret weapon, and AI will only make it more valuable
Wed, Jun 24th 2026
Biotech and Pharma
What this biotech's volatile stock price tells you about the weight loss market right now
Fri, Jun 19th 2026
Health and Science
UniQure to seek FDA approval for Huntington's disease gene therapy in reversal
Tue, Jul 21st 2026
Pharmaceuticals
Biotech IPO revival faces competition from cash-rich big pharma buyers
Tue, Jun 16th 2026
Health and Science
Centene to offer buyouts to some employees as health insurer cuts costs
Mon, Jun 15th 2026
Health and Science
Drugmakers race to find a place in the next wave of obesity drugs
Sat, Jun 13th 2026
Load More
